CAS NO: | 170846-74-9 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | CHPG is a selectivemGluR5agonist, and attenuates SO2-induced oxidative stress and inflammation throughTSG-6/NF-κBpathway in BV2 microglial cells[1]. CHPG protects against traumatic brain injury (TBI) in vitro and in vivo by activation of theERKandAktsignaling pathways[2]. | ||||||||||||||||||||||||
IC50& Target |
| ||||||||||||||||||||||||
体外研究 (In Vitro) | CHPG (10-500 μM; 24 hours) significantly increases the cell viability and decreases the LDH release after SO2derivatives treatment[1]. Cell Viability Assay[1]
Apoptosis Analysis[1]
Western Blot Analysis[1]
| ||||||||||||||||||||||||
体内研究 (In Vivo) | CHPG (injection; 250 nM; for 7 days) reduces significantly cerebral lesion volume[2].
| ||||||||||||||||||||||||
分子量 | 201.61 | ||||||||||||||||||||||||
性状 | Solid | ||||||||||||||||||||||||
Formula | C8H8ClNO3 | ||||||||||||||||||||||||
CAS 号 | 170846-74-9 | ||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
储存方式 |
| ||||||||||||||||||||||||
溶解性数据 | In Vitro: 1M NaOH : 25 mg/mL(124.00 mM;ultrasonic and adjust pH to 11 with NaOH) DMSO :< 1 mg/mL (ultrasonic)(insoluble or slightly soluble) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |